Effect | Increase |
Trial Design | Double blind |
Trial Length | 2-4 Weeks |
Number of Subjects | 16 |
Sex | Both Genders |
Age Range | 18-29, 30-44 |
240mg Egb-761 over four weeks to depressed persons currently on therapy (trimipramine) was able to improve sleep efficiency by reducing the frequency of waking and increasing non-REM sleep, although REM sleep was unaffected.